Results 171 to 180 of about 15,449 (183)

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A

Vaccine, 2011
Moon Nahm
exaly  

Pneumococcal conjugate vaccine and pneumococcal common protein vaccines

2008
Steven Black, Juhani Eskola, Cynthia Whitney, Henry Shinefield   +3 more
openaire   +1 more source

The Impact of Age on the Efficacy of 13-valent Pneumococcal Conjugate Vaccine in Elderly

Clinical Infectious Diseases, 2015
C H Van Werkhoven, Marc Bonten, Diederick Grobbee   +2 more
exaly  

Multivalent pneumococcal conjugate vaccine

2017
RAMESH VENKAT MATUR, THIRUMENI NAGARAJAN, RAJENDAR BURKE, NARENDER DEV MANTENA, MAHIMA DATLA   +4 more
openaire   +2 more sources

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany

Vaccine, 2010
Christine Juergens, Emilio A Emini, Katrin Steul   +2 more
exaly  

Increase in Invasive Streptococcus Pneumoniae Infections in Children with Sickle Cell Disease since Pneumococcal Conjugate Vaccine Licensure

Journal of Pediatrics, 2011
Charles T Quinn, Zora R Rogers
exaly  

PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE

2007
BIEMANS RALPH LEON, GARCON NATHALIE MARIE-JOSEPHE, HERMAND PHILIPPE VINCENT, POOLMAN JAN, VAN MECHELEN MARCELLE PAULETTE   +4 more
openaire   +5 more sources

Pneumococcal conjugate vaccine formulations

2018
SMITH WILLIAM, GIOVARELLI CECILIA, NAWROCKI DENISE   +2 more
openaire   +2 more sources

Pneumococcal Conjugate Vaccines

2012
openaire   +1 more source

Pneumococcal Conjugate Vaccines: Review and Update

Microbial Drug Resistance, 1995
openaire   +2 more sources